0

Global Osteonecrosis Therapeutics Market 2019-2023

  • Published: Nov 2018
  • Pages: 121
  • SKU: IRTNTR30330
Technavio

The 2022-2026 version of this report is just being published. Buy it now and get up to $1000 worth of free customization!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The global osteonecrosis therapeutics market size will grow by USD 220.49 million during 2019-2023. This industry research report provides a detailed analysis of the market based on product (non-steroidal anti-inflammatory drugs (NSAIDs) and other therapeutics) and geography (the Americas, APAC and EMEA). The report analyzes the market’s competitive landscape and offers information on several osteonecrosis therapeutics manufacturers including Atnahs, Merck Sharp & Dohme, Mylan, Pfizer and Teva Pharmaceutical Industries.

Below are some of the key findings from this osteonecrosis therapeutics market analysis report:

 Osteonecrosis Therapeutics Market

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.

Get a FREE sample now!

     

Global osteonecrosis therapeutics industry overview

The rising awareness about osteonecrosis is driving the global osteonecrosis therapeutics market. To avoid delay in diagnosis and make individuals aware of the treatment for osteonecrosis, various government and non-government organizations are organizing programs and campaigns to facilitate speedy treatment. The increasing awareness about osteonecrosis among patients will drive market growth.

The introduction of stem cell therapy is positively impacting the global osteonecrosis therapeutics market. Stem cell therapy can replace damaged bone cells, cure the affected part,  and this therapy has fewer side-effects than the available treatments. Owing to such advantages of stem cell therapy, several patients are opting for osteonecrosis treatment using stem cells which is driving the osteonecrosis therapeutics market. Thus, the rising awareness about osteonecrosis coupled with the introduction of stem cell therapy will drive the osteonecrosis therapeutics market growth at a CAGR of more than 6% during the forecast period.

Top osteonecrosis therapeutics companies covered in this report

The global osteonecrosis therapeutics market is highly fragmented. By offering a complete analysis of the market's competitive landscape and with information on the products offered by the companies, this osteonecrosis therapeutics industry analysis report will aid clients to identify new growth opportunities and design new growth strategies.

The report offers a detailed analysis of several leading osteonecrosis therapeutics companies including:

  • Atnahs
  • Merck Sharp & Dohme
  • Mylan
  • Pfizer
  • Teva Pharmaceutical Industries

 Osteonecrosis therapeutics market segmentation based on product

  • NSAIDs
  • Other therapeutics

NSAIDs were the dominating product segment of the global osteonecrosis therapeutics market in 2018. The market share of this segment will increase, and it will continue to dominate the market throughout the next five years. This is because NSAIDs are considered as the primary treatment option for osteonecrosis.

Osteonecrosis therapeutics market segmentation based on region

  • The Americas
  • APAC
  • EMEA

The Americas accounted for the largest osteonecrosis therapeutics market share in 2018. This region will remain the market leader for the next five years. This is because of a well-defined healthcare infrastructure across several countries in this region.

Key highlights of the global osteonecrosis therapeutics market for the forecast years 2019-2023:

  • CAGR of the market during the forecast period 2019-2023
  • Detailed information on factors that will accelerate the growth of the osteonecrosis therapeutics market during the next five years
  • Precise estimation of the global osteonecrosis therapeutics market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the osteonecrosis therapeutics industry across the Americas, APAC, and EMEA
  • A thorough analysis of the market's competitive landscape and detailed information on several vendors
  • Comprehensive details on factors that will challenge the growth of osteonecrosis therapeutics companies

 

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

 

Read More Read Less

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2028

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • NSAIDs - Market size and forecast 2018-2023
  • Other therapeutics - Market size and forecast 2018-2023
  • Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • Americas - Market size and forecast 2018-2023
  • EMEA - Market size and forecast 2018-2023
  • APAC - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Introduction of stem cell therapy
  • Strategic alliances
  • Increasing research for the diagnosis of osteonecrosis

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Atnahs
  • Merck Sharp & Dohme
  • Mylan
  • Pfizer
  • Teva Pharmaceutical Industries 

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations

PART 15: EXPLORE TECHNAVIO

 

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your FREE sample now!
Safe and Secure SSL Encrypted
Technavio

Single User:

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase
Technavio
Enquire Before Buying
  1. Home
  2. Health Care
  3. Published Reports 2019
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>